GlassScriptPhysician profile
Jill E Fritz
NPI 1720146947
$3,513.38
in general payments reported to CMS, 2019-2025
33 companies · $1,167 in 2025
The $1,167 reported for 2025 was more than what 87% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $111 · 2022: $463 · 2023: $671 · 2024: $1,101 · 2025: $1,167.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,771 · Education: $169.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,770.53 |
| Education | $168.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $603.47 | 2022-2025 | Fasenra, Breztri, Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $288.74 | 2021-2025 | Ofev, Jascayd, Spiriva Respimat |
| Jazz Pharmaceuticals INC. | $251.41 | 2023-2025 | |
| Grifols USA, LLC | $247.24 | 2021-2025 | Prolastin-C Liquid, Xembify, Gamunex-C |
| Regeneron Healthcare Solutions, INC. | $166.74 | 2024-2025 | Dupixent |
| Mylan Specialty L.P. | $153.58 | 2022-2024 | Yupelri |
| Glaxosmithkline, LLC. | $151.36 | 2022-2025 | Nucala, Arexvy |
| Csl Behring | $138.00 | 2022-2024 | Kcentra |
| United Therapeutics Corporation | $131.56 | 2023-2025 | Tyvaso |
| Baxter Healthcare | $128.28 | 2022-2024 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Amgen INC. | $119.22 | 2022-2025 | Tezspire |
| Genentech USA, INC. | $113.92 | 2024-2025 | Xolair |
| Merck Sharp & Dohme LLC | $100.78 | 2022-2025 | Zerbaxa, Recarbrio |
| Viatris Specialty LLC | $83.94 | 2025 | Yupelri |
| Novartis Pharmaceuticals Corporation | $76.72 | 2022-2025 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $75.51 | 2022-2025 | Uptravi, Opsynvi, Opsumit |
| Mallinckrodt Hospital Products INC. | $69.22 | 2021-2024 | Acthar |
| Ani Pharmaceuticals, INC. | $68.06 | 2022-2024 | Purified Cortrophin Gel |
| Idorsia Pharmaceuticals US INC | $67.24 | 2022-2024 | Quviviq |
| Axsome Therapeutics, INC. | $59.16 | 2024-2025 | Sunosi |
| Abbvie INC. | $57.74 | 2022-2024 | |
| Teva Pharmaceuticals USA, INC. | $52.60 | 2021-2023 | |
| Lilly USA, LLC | $49.07 | 2025 | Zepbound |
| Pfizer INC. | $48.86 | 2022-2025 | |
| Verona Pharma, INC. | $46.09 | 2025 | Ohtuvayre |
| Philips North America LLC | $33.20 | 2024-2025 | Vest Therapy Und, (Ak6) Vest Therapy |
| Avadel Cns Pharmaceuticals, LLC | $27.09 | 2024 | Lumryz |
| Insmed, INC. | $24.47 | 2025 | Arikayce |
| Shionogi INC | $20.59 | 2024 | Fetroja |
| Zoll Respicardia, INC. | $20.04 | 2023 | Remede System |
| Electromed, INC. | $15.82 | 2024 | Smartvest |
| Pulmonx Corporation | $13.37 | 2022 | |
| Breas Medical, INC. | $10.29 | 2025 | Vivo 45 Ls, Vivo 1/2 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jill Fritz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.